- Home
- RCKT vs PRG Comparison
RCKT vs PRG Comparison
Compare RCKT & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | PRG |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 1.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | RCKT | PRG |
|---|---|---|
| Price | $4.40 | $27.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $29.65 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 2.8M | 563.7K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.59 |
| Revenue | N/A | ★ $2,409,223,000.00 |
| Revenue This Year | N/A | $25.27 |
| Revenue Next Year | $97.68 | $6.59 |
| P/E Ratio | ★ N/A | $7.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.19 | $23.50 |
| 52 Week High | $8.80 | $41.14 |
Technical Indicators
Market Signals| Indicator | RCKT | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 31.68 |
| Support Level | $2.99 | $27.39 |
| Resistance Level | $4.51 | $30.68 |
| Average True Range (ATR) | 0.35 | 1.22 |
| MACD | -0.08 | -0.64 |
| Stochastic Oscillator | 17.83 | 7.44 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.